谁的水平高,帮把这个翻成中文?


所有跟贴·加跟贴·新语丝读书论坛

送交者: 猎人 于 2011-04-10, 19:38:55:

第一个试验(NCT00378664):

Official Title: Lumbar to Sacral Ventral Nerve Re-Routing

Study Design: Endpoint Classification: Efficacy Study

Primary Outcome Measures: Assess the level of improvement in voiding function after lumbar to sacral ventral nerve re-routing procedure in SCI and spina bifida patients. [time frame: evaluated at 6 months and 1 year ][designated as safety issue: no]

第二个试验(NCT01096459):

Official Title: Safety and Efficacy of Nerve Rerouting for Treating Neurogenic Bladder in Spina Bifida

Study Design: Endpoint Classification: Safety/Efficacy Study

Primary Outcome Measures: Reproducible bladder contraction [time frame: 6 to 24 months post procedure] [designated as safety issue: yes]

Secondary Outcome Measures: Transfer of knowledge to other personnel to learn the procedure [time frame: two years] [designated as safety issue: yes].




所有跟贴:


加跟贴

笔名: 密码: 注册笔名请按这里

标题:

内容: (BBCode使用说明